The Pathogenesis and Natural History of Sjogren s Syndrome

  • STATUS
    Recruiting
  • participants needed
    300
  • sponsor
    National Institute of Dental and Craniofacial Research (NIDCR)
Updated on 30 March 2021
fatigue
vasculitis
arthritis
dry eyes
keratoconjunctivitis sicca

Summary

Background

-Sjogren s syndrome is a disease that affects about 1-4 million Americans. It is more common in women. It mainly affects the glands that produce saliva and tears, leading to dry eyes and dry mouth. The cause of Sjogren s syndrome is unknown, but inflammation plays an important role. The purpose of this study is to learn more about Sjogren s syndrome.

Objectives

-To better understand how Sjogren s syndrome begins and how it affects patients so that we can develop better ways to treat them.

Eligibility
  • Participants must be 16 years of age or older.
  • They must have a diagnosis of Sjogren s syndrome or have at least two symptoms of Sjogren s syndrome.
Design
  • People taking part in the study will come to the NIH Clinical Center for at least three visits.
  • During these visits, participants will have a medical history and physical exam. They will have oral and dental assessments, and saliva collection. Lab tests (blood and urine) and dry eye exams will be done. Participants will answer questionnaires and have salivary scintigraphy (adults only unless required for diagnosis).
  • Other optional tests may also be done. Participants may have to come in for additional visits if they have these optional tests or if their disease changes.
  • The only treatment provided as part of this study is for medical emergencies or complications that occur while you are at NIH for evaluation.

Description

BACKGROUND

Sj(SqrRoot)(Delta)gren s syndrome (SS) is an autoimmune disease characterized by chronic inflammation

involving the exocrine glands. Salivary and lacrimal glands are predominantly affected leading to dry mouth and dry eyes but other exocrine organs are also frequently involved. It is one of the most common rheumatic autoimmune diseases, which effects between 1-4 million Americans, predominantly women with a female to male ratio of 9:1. Sj(SqrRoot)(Delta)gren s syndrome may occur alone (primary SS), or may coexist with other systemic connective tissue disorders (secondary SS). In many cases systemic manifestations, such as fatigue, arthritis, vasculitis, lung disease, peripheral or central neuropathy and autonomic nervous system dysfunction accompany glandular involvement. Patients with systemic manifestations are at higher risk of lymphoma, the incidence of which is increased in SS. The treatment of sicca symptoms is mainly symptomatic, whereas management of extraglandular manifestations is similar to other autoimmune diseases.

The cause and pathogenesis of Sj(SqrRoot)(Delta)gren s syndrome is still largely unknown. In a genetically predisposed individual various environmental factors, such as viral infections, may lead to epithelial cell activation and a protracted inflammatory response with features of autoimmunity. Autoreactive lymphocytes and autoantibodies are considered important in this process although the pathogenic role of any particular autoantibody is still undefined. Although inflammation may contribute to the exocrinopathy of SS, the relationship between inflammation and exocrine dysfunction is poorly understood. Moreover, the model does not explain many of the extraglandular manifestations of SS patients, such as fatigue. Further studies are needed to better understand the pathogenesis of SS.

OBJECTIVES

The primary objective of this study is to enable the collection of longitudinal clinical and laboratory data and biologic specimens to identify pathogenetic mechanisms of SS by careful clinical phenotyping of SS patients and Sj(SqrRoot)(Delta)gren s-like conditions over time and collection of biologic samples for concurrent and future laboratory studies related to the pathogenesis of Sj(SqrRoot)(Delta)gren s syndrome. Another objective of the study is to identify biomarker candidates associated with the diagnosis, severity, prognosis, or organ involvement in SS.

The protocol will enable the study of the genetic basis and the mechanistic aspects of immunologic and non-immunologic abnormalities of SS and their associations with various clinical phenotypes.

ELIGIBILITY CRITERIA

The study will enroll 300 subjects with Sj(SqrRoot)(Delta)gren s syndrome or Sj(SqrRoot)(Delta)gren s-like conditions. Subjects aged 16- years or older fulfilling European American Consensus Criteria for Primary or Secondary Sj(SqrRoot)(Delta)gren s syndrome are eligible for the study. Selected subjects with incomplete Sj(SqrRoot)(Delta)gren s syndrome or who are excluded from the European American criteria may also be eligible. Screening will be done on the Characterization of Diseases with Salivary Gland Involvement protocol (15-D-0051) prospectively or on the previous screening protocol (84-D-0056).

DESCRIPTION OF THE STUDY

This is a longitudinal observational study. All subjects will have at least three core evaluations (approximately biannually) during a 4-5 year period. Additional evaluations may be required if there is a significant change in the clinical condition of subjects likely related to SS or sicca syndrome or to provide additional research samples or clinical data for the pathogenesis studies. Clinical data will be collected through questionnaires, personal interviews, physical examination, laboratory testing and imaging studies. The core evaluation will include a complete medical history and physical examination and a complete oral and dry eye evaluation. Research studies include salivary scintigraphy for functional assessment of salivary gland function, testing of the autonomous nervous system and may include an ultrasound guided parotid core needle biopsy. Blood, saliva and biopsy samples will be stored and used for laboratory research studies aimed at the pathogenesis of Sj(SqrRoot)(Delta)gren s syndrome. Samples labeled with a code without any personal identifiers may be shared with researchers in and outside the NIH. DNA will be collected for genetic studies related to Sj(SqrRoot)(Delta)gren s syndrome and related conditions.

Details
Condition Sicca Syndrome, etiology, Rheumatoid Arthritis, Xerostomia, Salivary gland, Salivary Gland Disease, Rheumatoid Arthritis (Pediatric), Saliva and Salivary Gland Dysfunction, Sjogren's Syndrome, Dry Mouth
Clinical Study IdentifierNCT01425892
SponsorNational Institute of Dental and Craniofacial Research (NIDCR)
Last Modified on30 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 16 yrs?
Gender: Male or Female
Do you have any of these conditions: Salivary gland or etiology or Sjogren's Syndrome or Sicca Syndrome or Rheumatoid Arthritis (Pediatric) or Xerostomia or Saliva and Salivary Gland Dysf...?
Do you have any of these conditions: Rheumatoid Arthritis or Salivary gland or etiology or Rheumatoid Arthritis (Pediatric) or Dry Mouth or Xerostomia or Sicca Syndrome or Salivary Gland ...?
Do you have any of these conditions: etiology or Rheumatoid Arthritis (Pediatric) or Salivary Gland Disease or Xerostomia or Rheumatoid Arthritis or Saliva and Salivary Gland Dysfunction ...?
Do you have any of these conditions: Dry Mouth or Salivary Gland Disease or etiology or Rheumatoid Arthritis (Pediatric) or Sjogren's Syndrome or Salivary gland or Rheumatoid Arthritis or...?
Do you have any of these conditions: Salivary gland or Rheumatoid Arthritis (Pediatric) or Saliva and Salivary Gland Dysfunction or Rheumatoid Arthritis or Dry Mouth or etiology or Xerost...?
Do you have any of these conditions: Rheumatoid Arthritis or Sjogren's Syndrome or etiology or Xerostomia or Sicca Syndrome or Salivary gland or Rheumatoid Arthritis (Pediatric) or Saliva...?
Do you have any of these conditions: Salivary gland or Dry Mouth or Saliva and Salivary Gland Dysfunction or Rheumatoid Arthritis or Sicca Syndrome or Rheumatoid Arthritis (Pediatric) or ...?
Do you have any of these conditions: Rheumatoid Arthritis or Saliva and Salivary Gland Dysfunction or Sjogren's Syndrome or Salivary Gland Disease or Dry Mouth or Xerostomia or Rheumatoid...?
Do you have any of these conditions: Salivary Gland Disease or Rheumatoid Arthritis or Sicca Syndrome or Dry Mouth or Saliva and Salivary Gland Dysfunction or Rheumatoid Arthritis (Pediat...?
Ability to sign informed consent form
Fulfilling one the definitions below
Sj(SqrRoot)(Delta)gren s defined by European-American (EA) classification criteria for primary or secondary Sj(SqrRoot)(Delta)gren s syndrome (SS group)
Excluded from the EA criteria because of a comorbid condition but otherwise fulfilling the European-American classification criteria (EA excluded SS group)
Incomplete SS
at least 2 of the EA criteria with a common manifestation of SS not included in these criteria (e.g., fatigue, vasculitis, arthritis, etc)
ii. 2 or more common manifestations of SS which are not included in the EA
criteria (e.g.,: fatigue, vasculitis, arthritis, autonomic dysfunction, etc )
and are not explained by other conditions

Exclusion Criteria

Age <16 years
inability or unwillingness to comply with follow up requirements
Any medical or psychological/psychiatric condition or treatment that, in the opinion of the Principal Investigator, would exclude the subjects from the research studies (e.g., alternative explanation for subjects signs and symptoms)
NIH employees who report directly to the principal investigator or who are a co-worker or relative of the principal investigator
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note